New Endgames for Tobacco: Radical, Visionary, or Both?

Wednesday, August 15, 2012: 3:00 PM
1501C (Kansas City Convention Center)
Prof. Robert N. Proctor, PhD , History, Stanford University, Stanford, CA
Dr. Cheryl Healton, Dr.P.H. , American Legacy Foundation, Washington, DC
Dr. Ruth Malone, RN, PhD , Social and Behavioral Sciences, University of California, San Francisco, San Francisco, CA
Mr. Bob Doyle, BS Marketing-Advertising , Colorado Tobacco Education and Prevention Alliance, Aurora, CO

Learning Objectives

At the conclusion of this presentation attendees will be able to:

  1. Identify the limitations and obstacles to current strategies acheiving significant reductions in use, disease, and death
  2. Demonstrate the need for conisderation of alternative strategies
  3. Describe alternative endgame strategies

Cross Cutting Program Area(s): Tobacco Control Policies

Audience: The panel discussion will be for new and experienced public health professionals and advocates.

Key Points: The data surrounding tobacco use clearly show a public health emergency, not just a public health issue. But do our actions reflect an emergency or urgency? With more than 1 billion expected to die worldwide in the 21st Century, it's imperative to examine the potential of our current strategies and explore new directions that could have a more dramatic impact on tobacco related death and disease. The discussion will examine past and current strategies of the public health community, the countering actions of the tobacco industry, and the obstacles that could prevent a significant reduction in death and disease. We will present the need to examine new approaches, and provide new Endgame ideas, their challenges, and public health potential. The purpose is not to promote one Endgame idea but the need for considering new ideas and their potential for greater public health results.

Educational Experience: Attendees will understand the past and present actions to reduce the burden of tobacco use and the actions by the tobacco industry. The audience will know the possible public health outcomes with our current focus and obstacles, the need to look at alternatives, and potential benefit and challenges to new Endgame ideas.

 Benefits: The panelists will provide expertise on the history of tobacco control and tobacco industry, best and innovative practices to address tobacco, and the possibilities and unknowns of new Endgame ideas for tobacco.